Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (4), 987-995
- https://doi.org/10.1016/s0360-3016(00)01529-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- High-dose-rate intraoperative brachytherapy for recurrent colorectal cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02JNCI Journal of the National Cancer Institute, 2000
- Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancerDiseases of the Colon & Rectum, 1997
- Improving Adjuvant Therapy for Rectal Cancer by Combining Protracted-Infusion Fluorouracil with Radiation Therapy after Curative SurgeryNew England Journal of Medicine, 1994
- Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancerCancer, 1994
- Pelvic radiation therapy in rectal cancer: Technical considerationsSeminars in Radiation Oncology, 1993
- Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancerCancer, 1991
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986